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Regioselective functionalisation of
dibenzothiophenes through gold-catalysed
intermolecular alkyne oxyarylation†
Matthew J. Barrett, Paul W. Davies* and Richard S. Grainger*
A protocol has been developed for direct Csp3–Csp2 bond formation at the 4- and 6-positions of dibenzo-
thiophenes using a gold(I) catalyst with terminal alkynes and dibenzothiophene-S-oxides. The sulfoxide
acts as a traceless directing group to avoid the need to prefunctionalise at carbon. The iterative use of this
protocol is possible and has been employed in the preparation of novel macrocyclic structures. In
addition, a cascade process shows how oxyarylations can be combined with other processes resulting in
complex, highly eﬃcient transformations.
Introduction
Dibenzothiophenes are aromatic sulfur-containing hetero-
cycles of broad utility. The optical, redox and conducting pro-
perties of dibenzothiophenes and their corresponding
S,S-dioxides have led to applications in materials science.1
S-Substituted dibenzothiophenes are used as precursors to
triphenylenes2 and as a platform for the transfer of reactive
species such as F3C
+ (Umemoto’s reagent),3 atomic oxygen
(O(3P)),4 nitrenes5 and carbenes.6 Biological and medicinal
chemistry applications of dibenzothiophenes and their
S-oxides have also been reported.7
Functionalised dibenzothiophenes are generally prepared
through one of two main approaches. Late stage formation of
the dibenzothiophene core has been achieved through intra-
molecular C–S8 or C–C (biaryl)9 bond formation and benz-
annulation of thiophenes or benzothiophenes.10 Alternatively,
dibenzothiophene undergoes regioselective bromination at the
2,8-positions11 or the 3,7-positions of the corresponding
S,S-dioxide.12 Substitution at the 4- and 6-positions however
requires stoichiometric metallation using organolithium or
organoaluminium reagents.13,14 Here we report a catalysis-
based approach for direct carbon–carbon bond formation at
the unfunctionalised 4- and 6-positions of dibenzothiophenes
under mild and functional group tolerant conditions.
Our interests in aromatic S-oxide chemistry15 and π-acid
catalysis16 led us to investigate whether 4-substituted
dibenzothiophenes could be accessed in an expedient fashion
from dibenzothiophene S-oxides by a gold-catalysed alkyne
oxyarylation.17–19 This approach should be regiospecific, instal-
ling a Csp3–Csp2 bond with transfer of the oxygen atom
to generate the synthetically versatile α-arylcarbonyl motif
(Scheme 1).20
Following the introduction of alkyne oxyarylation with sulf-
oxides in gold-catalysed intramolecular cycloisomerisations
by the groups of Toste17a and Zhang,17b the viability of
an intermolecular process was shown by Ujaque, Asensio and
co-workers (Scheme 2).17c
This and subsequent17d,e studies established that such pro-
cesses are regiospecific by virtue of proceeding via a [3,3]-
sigmatropic rearrangement of the vinyl gold carbenoid B
formed on attack of the sulfoxide to the gold–alkyne complex
(Scheme 2, A→ C).21
Despite sulfoxide-based alkyne oxyarylation oﬀering sub-
stantial potential for atom-economic, functional group tolerant
and direct intermolecular aryl C–H functionalisation routes
into challenging aromatic substitution patterns, they have
Scheme 1 Proposed regiospeciﬁc functionalisation of dibenzothio-
phenes using the S-oxide as a traceless directing group.
†Electronic supplementary information (ESI) available: General experimental
procedures, additional example of iterative process and NMR spectra for new
compounds. CCDC 1405198. For ESI and crystallographic data in CIF or other
electronic format see DOI: 10.1039/c5ob01241d
School of Chemistry, University of Birmingham, Haworth Building, Edgbaston,
Birmingham, B15 2TT, UK. E-mail: p.w.davies@bham.ac.uk,
r.s.grainger@bham.ac.uk
This journal is © The Royal Society of Chemistry 2015 Org. Biomol. Chem.
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been rarely employed in synthesis. In large part this can be
assigned to the challenges of ensuring that the key aromaticity-
disrupting [3,3]-sigmatropic rearrangement (B→ C) is favoured
over elimination of a sulfide nucleofuge (B → D), or competing
inter- or intra-molecular attack of a nucleophile (B → E).17,22,23
In addition, structural elaboration of the sulfoxide must not
prevent it from being suﬃciently nucleophilic to intercept the
alkyne–gold complex A, yet not force further reaction at B to
aﬀord the biscarbonyl G alongside two equivalents of
sulfide.24,25
Results and discussion
The viability of selective elaboration of a dibenzothiophene
through an alkyne oxyarylation approach was investigated
using dibenzothiophene-S-oxide 1 and hex-1-yne 2a. Applying
the combination of Ph3PAuCl/AgSbF6 in superheated CH2Cl2
from Asensio’s work17c generated a mixture of dibenzo-
thiophenes 3a and 4 in high yield with the desired oxyarylation
product 3a as the minor component (Table 1, entry 1).
An investigation of the reaction conditions was undertaken
to explore the factors favouring the rearrangement pathway
over those leading to S–O bond cleavage and formation of 4
(Table 1). The most significant factors identified in this study
proved to be the use of electron-deficient rather than electron-
rich ligands on gold (compare entries 7 and 10 vs. 4, 8 and 9)
and the use of lower reaction temperatures (compare entries
13 and 14 vs. 11 and 1), which diﬀer substantially from those
conditions previously reported for the intermolecular oxyaryl-
ation reaction with sulfoxides.17c,d These observations are in
keeping with higher temperature and electron-density at the
gold centre being likely to increase the rate of elimination of
the sulfide nucleofuge (Scheme 2, B→ D).26,27
Scheme 2 General schematic for gold-catalysed oxyarylation reaction
of alkynes with sulfoxides.
Table 1 Study of the reaction conditions for oxyarylation using dibenzothiophene-S-oxidea
Entry Gold catalyst Solvent Time/h Temp/°C Conc. M Yield 1b/% Yield 3ab/% Yield 4b/% Ratio 3a : 4
1b Ph3PAuCl/AgSbF6
c CH2Cl2 16 70 1.0 0 37 61 1 : 1.6
2 Ph3PAuCl/AgSbF6
c ClCH2CH2Cl 16 70 1.0 10
d 20 30d —
3 Ph3PAuCl/AgSbF6
c CH3NO2 16 70 1.0 0 39 36 1.1 : 1
4 Ph3PAuCl/AgOTs
c CH3NO2 16 70 1.0 12 41 31 1.3 : 1
5 AuCl CH3NO2 16 70 1.0 52 4 22 1 : 5.5
6 AuPicolinateCl2 CH3NO2 16 70 1.0 36 4 24 1 : 6.0
7 (p-F3CC6H4)3PAuCl/AgOTs
c CH3NO2 16 70 1.0 5 42 24 1.8 : 1
8 XPhosAuCl/AgOTsc CH3NO2 16 70 1.0 51 10 24 1 : 2.4
9 JohnPhosAuCl/AgOTsc CH3NO2 16 70 1.0 52 8 24 1 : 3.0
10 (ArO)3PAuCl/AgOTs
c CH3NO2 16 70 1.0 <5 47 17 2.8 : 1
11 (ArO)3PAu(NCCH3)SbF6 CH3NO2 16 70 1.0 <5 48 16 3.0 : 1
12 (ArO)3PAu(NCCH3)SbF6 CH3NO2 3 70 0.1 <5 44 20 2.2 : 1
13 (ArO)3PAu(NCCH3)SbF6 CH3NO2 3 RT 0.1 8 67 10 6.7 : 1
14 (ArO)3PAu(NCCH3)SbF6 CH2Cl2 3 RT 0.1 <5 54 14 3.9 : 1
15 (ArO)3PAu(NCCH3)SbF6 CH3CN 3 RT 0.1 29 17 5 3.4 : 1
16 (ArO)3PAu(NCCH3)SbF6 Toluene 3 RT 0.1 0 84 8 10.5 : 1
17 (ArO)3PAu(NCCH3)SbF6 Toluene 3 0 0.1 0 91 8 11.4 : 1
a 1 (0.10 mmol), 2a (0.20 mmol). b Yields calculated by 1H-NMR spectroscopy against a known quantity of internal standard (1,2,4,5-
tetramethylbenzene). cCatalyst prepared by in situ combination of equimolar quantity of the (Ligand)AuCl with the appropriate Ag(counterion)
salt. dDue to overlap with unidentified resonances estimated yields were determined. XPhos = 2-dicyclohexylphosphino-2,4,6-
triisopropylbiphenyl; JohnPhos = (2-biphenyl)di-tert-butylphosphine; Ar = (2,4-di-tert-butylphenyl).
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Little counterion eﬀect was observed and similar results
were obtained with the single component catalyst system
(entries 10 and 11). Re-evaluating the solvent showed CH2Cl2
to be poor and that excellent selectivity was ultimately
obtained in toluene at 0 °C using (2,4-di-tert-BuC6H3O)3PAu-
(NCCH3)SbF6,
16d,28 aﬀording 3a in high yield (entry 17).
The use of dibenzothiophene-S-oxide 1 with diﬀerent term-
inal alkynes 2b–k was then studied in the oxyarylation reac-
tion: chloro, aryl, vinyl and phthalimide substituents were
well-tolerated as were the methyl and silyl-ethers, aﬀording
products 3b–k in generally good yields (Table 2, entries 2–7).29
The α-hydroxyketone oxyarylation product 3g was also formed
in high yield (entry 8) despite the potential for oxetan-3-one
formation by intramolecular capture of the vinylgold inter-
mediate by the propargylic alcohol, as reported using cationic
gold(I) catalysts and pyridine-N-oxides.30 This protocol proved
to be robust: a very similar yield was obtained even when the
reaction was run open to the air and using non-dried toluene
with only 1 mol% catalyst loading on larger scale (entries
4 and 5).
The use of phenyl acetylene gave lower yields and led to for-
mation of significant quantities of dibenzothiophene 4 under
the standard conditions (Table 2, entry 9). Further reducing
the temperature, which in-turn necessitated a higher dilution
to maintain solubility of 1, gave improved yields which were
also seen with other aryl alkynes, including thiophene and
o-bromobenzene (entries 10–13).
The 2,8-dibromo substitution pattern, which is useful for
further transformations in materials science applications,1 was
readily accommodated with S-oxide 5 reacting to aﬀord the
oxyarylation product 6 in good yield (Scheme 3).
The use of an ynamide under these reaction conditions did
not lead cleanly to the oxyarylation products, though the
complex mixture formed did indicate that 1 was functioning as
an eﬀective oxidant. In order to benchmark the potential suit-
ability of dibenzothiophene-S-oxide as an oxidant in gold cata-
lysis it was applied under the conditions previously reported
by Davies and co-workers for the oxidative transformation of
ynamides using pyridine N-oxides (Scheme 4).31 Under those
conditions 1 proved to be as, or more-, eﬀective than the
unsubstituted pyridine-N-oxide and substantially more
eﬀective than the diphenylsulfoxide in both the oxidative for-
mation of α,β-unsaturated imide 8 and α-oxoimide 10. Hence
1 may be considered as an alternative reagent to diphenyl-
sulfoxide in gold-catalysed oxidative processes.32,33
Toste and co-workers had previously reported that the gold-
catalysed reaction of 1,6-enynes in the presence of excess
diphenylsulfoxide led to the formation of aldehydes by intra-
molecular cyclisation and capture of the intermediate cyclo-
propyl gold carbene with sulfoxide.25 Given the higher
reactivity observed of 1 compared to diphenylsulfoxide
(Scheme 4), the reaction of enyne substrates 11 was studied to
see whether 1 would be suﬃciently nucleophilic to allow the
intermolecular reaction of the sulfoxide at the gold–alkyne
complex to compete with intramolecular cycloisomerisation.
Table 2 Selective formation of C-4 substituted dibenzothiophenes
using diﬀerent alkynes
Entry R Cond. Mmol
Cat./
mol%
Time/
h
Yielda/
%
1 nBu A 0.2 5 0.75 87 3a
2 (CH2)3Cl A 0.2 5 0.75 79 3b
3 (CH2)2Ph A 0.2 5 0.75 65 3c
4 CH2OMe A 0.2 5 0.75 87 3d
5 CH2OMe A 2.0 1 2 84 3d
6 (CH2)4OTBDPS A 0.5 1 2 82 3e
7 CH2NPhth A 2.0 5 20
b 52 3f
8 CH(OH)nC7H15 A 0.2 5 20
b 76 3g
9 Ph A 0.1 5 1.5 48c 3h
10 Ph B 0.3 5 20 58 3h
11 2-BrC6H4 B 0.2 5 20 40 3i
12 4-MeOC6H4 B 0.2 5 20 42 3j
13 2-Thienyl B 0.2 5 20 62 3k
a Yields of isolated material after flash chromatography. bReactions
stirred for 4 h at 0 °C then warmed to rt over 16 hours. c Yield
calculated by 1H-NMR spectroscopy against a known quantity of
internal standard (1,2,4,5-tetramethylbenzene).
Scheme 3 Use of substituted dibenzothiophene S-oxide.
Scheme 4 Comparison of reactivity in oxidative transformation of
ynamides. Yield of known compounds 8 and 10 determined by 1H NMR
against an internal standard.
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Under our standard conditions the 1,6-enynes 11a and 11c
reacted cleanly to give the oxyarylation products 12a/c in high
yield (Scheme 5). In contrast, the cinnamyl derivative 11b and
the malonate-derived enyne 11d led to the aldehydes 13b/d
with low conversion. On this basis, the relatively high eﬃcacy
of dibenzothiophene S-oxide 1 as a nucleophile towards gold
alkyne complexes allows it to compete with an intramolecular
enyne cycloisomerisation so long as the latter pathway is not
strongly biased toward cyclisation by reactive rotamer eﬀects
or use of more electron-rich alkenes. Products arising from
capture of the vinyl gold carbenoid by the tethered alkene were
not observed.34
Iterative application of the oxyarylation reaction was then
tested to selectively functionalise both the 4- and 6-positions
of dibenzothiophene (Scheme 5). The gold-catalysed reactions
of 14, from selective oxidation of 12a using mCPBA,35 with 1,6-
and 1,7-enynes 11a and 15 aﬀorded high yields of the 4,6-dis-
ubstituted dibenzothiophenes 16a/b respectively. A similar
iterative process was also successfully applied to 3d (see ESI†
for details). While a higher catalyst loading and dilution were
required for the second iteration, the compatibility of this
approach with the flanking alkene and keto-functionality high-
lights the potential of using intermolecular oxyarylation
approaches with substantially more-functionalised sulfoxides.
Ring-closing metathesis of dienes 16a/b furnished the new
symmetrical and unsymmetrical macrocyclic products 17a/b in
good yield, isolated as trans double bond isomers. The double
bond geometry in 17a was determined to be trans through
X-ray crystallography (Fig. 1).‡
In addition to regiospecific formation of the Csp2–Csp3
bond the simultaneous installation of a methylenecarbonyl
moiety introduces a potentially useful handle for elaboration.
We explored this in two ways: first, a classical Fischer-indole
synthesis from 3h (yield unoptimised, Scheme 6) aﬀords the
3-dibenzothiophene indole motif 18.7i Thus an alternative is
proﬀered to the standard cross-coupling strategies requiring
prefunctionalisation of substrates for the formation of biaryl-
Scheme 5 The use of enynes in the oxyarylation process and appli-
cation in an iterative approach to access 4,6-disubstituted dibenzo-
thiophenes and subsequently macrocycles. a 2 mol% for 11a and 5 mol%
for 11b–d.
Fig. 1 Crystal structure of macocycle 17a with ellipsoids drawn at the
50% probability level.
Scheme 6 Utilising the introduced ketomethylene group in (a) for-
mation of a dibenzothienylindole as alternative to cross coupling,
(b) cascade catalysis.
‡Crystal structure determination of 17a. Crystal data for C22H20O4S, M = 380.44,
triclinic, space group P1ˉ (no. 2), a = 9.0122(4) Å, b = 10.2941(6) Å, c = 10.6266(6)
Å, α = 75.079(5)°, β = 73.655(4)°, γ = 75.040(5)°, V = 895.60(9) Å3, Z = 2, T =
100.00(10) K, μ(CuKα) = 1.826 mm−1, Dcalc = 1.411 g cm−3, 4979 reflections
measured (8.85° ≤ 2Θ ≤ 136.478°), 3193 unique (Rint = 0.0141, Rsigma = 0.0201)
which were used in all calculations. The final R1 was 0.0290 (I > 2σ(I)) and wR2
was 0.0733 (all data). CCDC 1405198.
Paper Organic & Biomolecular Chemistry
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linkages at the 4-position of dibenzothiophene. Second, a
cascade process using 1,6-diyne 19 provides direct access into
the α-arylated cyclohexenone 20 in a single step (Scheme 6).
Gold-catalysed cycloisomerisation of the 1,5-ketoalkyne gener-
ated from intermolecular oxyarylation results in formation of
five new bonds across the alkyne including three carbon–
carbon bonds at one carbon. The formation of bisketone 21 as
a side-product alongside the major product 20 is consistent
with the hydration/aldol dehydration pathway Davies and
Detty-Mambo previously reported in cycloisomerisation
of alkynes tethered to unactivated, enolisable ketones in the
presence of cationic gold(I) species.36
Conclusions
Conditions have been developed for regioselective formation
of Csp2–Csp3 bonds at the 4- and 6-positions of dibenzothio-
phenes without prior C-functionalisation. Selectivity for the
oxyarylation pathway is favoured by lower temperature and
electron-poor ligands on gold. The reactions allow for the
introduction of a variety of functionality under robust, scalable
conditions. Substantially more elaborate aryl sulfoxides can be
used in the oxyarylation approach as demonstrated in an itera-
tive application, which in conjunction with enyne substrates
was used to access new macrocyclic structures. In addition, the
use of the oxyarylation reaction as the basis for further cascade
process development has been demonstrated.
Experimental†
General oxyarylation procedure 1 (GP1), Table 2, conditions A
The dibenzothiophene-S-oxide (1 eq.) and alkyne (2 eq.) were
stirred in toluene (0.1 M) until dissolved. The mixture was
then cooled in an ice bath at 0 °C and the catalyst, (2,4-di-tert-
butylC6H3O)3PAu(NCCH3)SbF6 (1–5 mol%), was added. The
reaction mixture was stirred until TLC showed consumption of
dibenzothiophene-S-oxide, filtered through a pad of silica,
washing with CH2Cl2 before being concentrated and the
residue purified by column chromatography.
General oxyarylation procedure 2 (GP2), Table 2, conditions B
The dibenzothiophene-S-oxide (1 eq.) and alkyne (2 eq.) were
stirred in toluene (0.01 M) until dissolved. The mixture was
then cooled in a (NaCl/ice) bath to −10 °C and the catalyst,
(2,4-di-tert-butylC6H3O)3PAu(NCCH3)SbF6 (5 mol%) was added.
The reaction mixture was stirred for 6 hours at this tempera-
ture and then allowed to warm to stir at rt for 14 hours, filtered
through a pad of silica washing with CH2Cl2 before being con-
centrated and the residue purified by column chromatography.
Alkynes 11a, 3-(prop-2-yn-1-yloxy)prop-1-ene (54 wt% in
Et2O), and 15, 4-(prop-2-yn-1-yloxy)but-1-ene (77 wt% in Et2O),
were both used with a diethyl ether impurity.
1-(Dibenzo[b,d]thiophen-4-yl)hexan-2-one (3a)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40.0 mg, 0.2 mmol), 1-hexyne (23 µl, 0.4 mmol), toluene
(2 mL) and catalyst (11.2 mg, 0.02 mmol, 5 mol%). The reac-
tion was stirred for 45 minutes at 0 °C. Column chromato-
graphy (1 : 19 EtOAc : hexane) aﬀorded 3a (49 mg, 87%) as a
white solid; Rf 0.28 (1 : 19 EtOAc : hexane); mp: 43–45 °C;
1H-NMR (300 MHz, CDCl3): δ = 8.20–8.13 (m, 1H), 8.10
(d, J 7.2, 1H), 7.92–7.82 (m, 1H), 7.51–7.43 (m, 3H), 7.32 (d,
J 7.2, 1H), 3.96 (s, 2H), 2.51 (t, J 7.4, 2H), 1.63–1.50 (m, 2H),
1.33–1.19 (m, 2H), 0.85 (t, J 7.3, 3H); 13C-NMR (101 MHz,
CDCl3): δ = 207.5 (C), 140.0 (C), 139.1 (C), 136.1 (C), 136.0 (C),
129.2 (C), 128.0 (CH), 127.0 (CH), 125.2 (CH), 124.7 (CH), 123.0
(CH), 122.0 (CH), 120.6 (CH), 49.4 (CH2), 42.0 (CH2), 26.0
(CH2), 22.3 (CH2), 14.0 (CH3); IR (neat): ν = 3057, 2957, 2930,
2872, 1708, 1584, 1404, 749; HR-MS (ES-TOF): m/z: calcd for
C18H18ONaS: 305.0976, found 305.0978 [M + Na]
+.
6-Chloro-1-(dibenzo[b,d]thiophen-4-yl)hexan-2-one (3b)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40.0 mg, 0.2 mmol), 6-chloro-1-hexyne (48.5 µL, 0.4 mmol),
toluene (2 mL) and catalyst (11.2 mg, 0.02 mmol, 5 mol%).
The reaction was stirred for 45 minutes at 0 °C. Column
chromatography (9 : 11 CH2Cl2 : hexane) aﬀorded 3b as a
yellow oil (50 mg, 79%); Rf 0.44 (9 : 11 CH2Cl2 : hexane);
1H-NMR (300 MHz, CDCl3): δ = 8.18–8.12 (m, 1H), 8.09 (dd,
J 7.9 and 0.9, 1H), 7.91–7.83 (m, 1H), 7.54–7.42 (m, 3H), 7.32
(d, J 7.2, 1H), 3.95 (s, 2H), 3.50–3.42 (m, 2H), 2.59–2.50 (m,
2H), 1.76–1.66 (m, 4H); 13C-NMR (101 MHz, CDCl3): δ = 206.6
(C), 139.9 (C), 139.0 (C), 136.2 (C), 136.1 (C), 129.0 (C), 128.0
(CH), 127.0 (CH), 125.2 (CH), 124.8 (CH), 123.0 (CH), 122.0
(CH), 120.7 (CH), 49.4 (CH2), 44.7 (CH2), 41.1 (CH2), 31.8
(CH2), 21.1 (CH2); IR (neat): ν = 3060, 2953, 1711, 1584, 1443,
1401, 749; HR-MS (ES-TOF): m/z: calcd for C18H17ONaS
35Cl:
339.0586, found 339.0574 [M + Na]+.
1-(Dibenzo[b,d]thiophen-4-yl)-4-phenylbutan-2-one (3c)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40.0 mg, 0.2 mmol), 4-phenyl-1-butyne (56 µl, 0.4 mmol),
toluene (2 mL) and catalyst (11.2 mg, 0.02 mmol, 5 mol%).
The reaction was stirred for 45 minutes at 0 °C. Column
chromatography (1 : 1 hexane : CH2Cl2) aﬀorded 3c (43 mg,
65%) as a white solid; Rf 0.78 (3 : 7 EtOAc : hexane); mp:
102–104 °C; 1H-NMR (300 MHz, CDCl3): δ = 8.04–7.96 (m, 1H),
7.93 (d, J 7.8, 1H), 7.74–7.66 (m, 1H), 7.38–7.26 (m, 3H),
7.15–6.93 (m, 6H), 3.78 (s, 2H), 2.79–2.63 (m, 4H); 13C-NMR
(101 MHz, CDCl3): δ = 206.3 (C), 140.9 (C), 140.0 (C), 139.0 (C),
136.2 (C), 136.1 (C), 128.9 (C), 128.6 (2CH), 128.5 (2CH), 128.0
(CH), 127.0 (CH), 126.2 (CH), 125.2 (CH), 124.7 (CH), 123.0
(CH), 122.0 (CH), 120.7 (CH), 49.6 (CH2), 43.7 (CH2), 29.9
(CH2); IR (neat): ν = 3058, 3027, 2877, 1706, 1601, 1583, 1403,
1046, 746; HR-MS (ES-TOF): m/z: calcd for C22H18ONaS:
353.0976, found 353.0991 [M + Na]+.
Organic & Biomolecular Chemistry Paper
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1-(Dibenzo[b,d]thiophen-4-yl)-3-methoxypropan-2-one (3d)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40.0 mg, 0.2 mmol), methyl propargyl ether (33.8 µl,
0.4 mmol), toluene (2 mL) and catalyst (11.2 mg, 0.02 mmol,
5 mol%). The reaction was stirred for 45 minutes at 0 °C.
Column chromatography (CH2Cl2) aﬀorded 3d (47 mg, 87%)
as a yellow solid; Rf 0.31 (3 : 7 EtOAc : hexane); mp: 51–53 °C;
1H-NMR (300 MHz, CDCl3): δ = 8.19–8.13 (m, 1H), 8.10 (d,
J 7.7, 1H), 7.91–7.83 (m, 1H), 7.52–7.43 (m, 3H), 7.34 (d, J 7.2,
1H), 4.13 (s, 2H), 4.03 (s, 2H), 3.41 (s, 3H); 13C-NMR (101 MHz,
CDCl3): δ = 204.7 (C), 140.0 (C), 138.9 (C), 136.2 (C), 136.1 (C),
128.2 (C), 128.1 (CH), 127.1 (CH), 125.2 (CH), 124.7 (CH), 123.0
(CH), 122.0 (CH), 122.0 (CH), 77.3 (CH2), 59.5 (CH3), 45.5
(CH2); IR (neat): ν = 2903, 1712, 1590, 1427, 1394, 1316, 1102,
759; HR-MS (ES-TOF): m/z: calcd for C16H14O2NaS: 293.0612,
found 293.0610 [M + Na]+. Open-flask protocol: To a 25 mL
RBF under an atmosphere of air was added dibenzothiophene-
S-oxide 1 (401 mg, 2.0 mmol), methyl propargyl ether (338 µl,
4.0 mmol) and toluene (technical grade) (20 mL). The flask
was placed in an ice bath and (2,4-di-tert-butylC6H3O)3PAu-
(NCCH3)SbF6 (22.4 mg, 0.002 mmol, 1 mol%) was added. The
reaction was stirred at this temperature for 2 hours until TLC
indicated reaction completion. Column chromatography
(CH2Cl2) aﬀorded 3d (456 mg, 84%).
6-((tert-Butyldiphenylsilyl)oxy)-1-(dibenzo[b,d]thiophen-4-yl)-
hexan-2-one (3e)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(100 mg, 0.5 mmol), tert-butyl(hex-5-yn-1-yloxy)diphenylsilane
(336 mg, 1.0 mmol), toluene (5 mL) and catalyst (11.2 mg,
2 mol%). The reaction was stirred for 2 hours at 0 °C. Column
chromatography (3 : 2 hexane : CH2Cl2) aﬀorded 3e (222 mg,
82%) as a viscous oil; Rf 0.31 (3 : 2 hexane : CH2Cl2);
1H-NMR
(300 MHz, CDCl3): δ = 8.20–8.13 (m, 1H), 8.09 (dd, J 7.9 and
0.9, 1H), 7.88–7.82 (m, 1H), 7.67–7.59 (m, 4H), 7.51–7.32 (m,
9H), 7.30 (d, J 7.3, 1H), 3.93 (s, 2H), 3.60 (t, J 6.2, 2H), 2.51 (t,
J 7.3, 2H), 1.77–1.60 (m, 2H), 1.53–1.40 (m, 2H), 1.01 (s, 9H);
13C-NMR (101 MHz, CDCl3): δ = 207.2 (C), 140.0 (C), 139.1 (C),
136.2 (C), 136.1 (C), 135.7 (4CH), 134.1 (2C), 129.7 (2CH), 129.2
(C), 128.0 (CH), 127.7 (4CH), 127.0 (CH), 125.2 (CH), 124.7
(CH), 123.0 (CH), 122.0 (CH), 120.6 (CH), 63.6 (CH2), 49.4
(CH2), 42.0 (CH2), 32.0 (CH2), 27.0 (3CH3), 20.4 (CH2), 19.4 (C);
IR (neat): ν = 2930, 2856, 1713, 1588, 1427, 1105; HR-MS
(ES-TOF): m/z: calcd for C34H36O2NaSiS: 559.2103, found
559.2102 [M + Na]+.
2-(3-(Dibenzo[b,d]thiophen-4-yl)-2-oxopropyl)isoindoline-
1,3-dione (3f)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(200 mg, 1.0 mmol), N-propargyl phthalimide (370 mg,
2.0 mmol) and catalyst (22.4 mg, 0.04 mmol, 2 mol%) for
4 hours at 0 °C and stirring for a further 16 hours at rt. The
precipitate formed was washed with toluene and then recrys-
tallized from hot EtOH aﬀording 3f as yellow crystals (201 mg,
52%); Rf 0.65 (3 : 7 EtOAc : hexane); mp: 190–192 °C (EtOH);
1H-NMR (300 MHz, CDCl3): δ = 8.20–8.15 (m, 1H), 8.13 (dd,
J 7.9 and 1.0, 1H), 7.90–7.85 (m, 1H), 7.85–7.78 (m, 2H),
7.75–7.67 (m, 2H), 7.54–7.44 (m, 3H), 7.40 (d, J 7.3, 1H), 4.56
(s, 2H), 4.11 (s, 2H); 13C-NMR (101 MHz, CDCl3): δ = 199.0 (C),
167.7 (2C), 140.0 (C), 139.0 (C), 136.5 (C), 136.1 (C), 134.2
(2CH), 132.1 (2C), 128.0 (CH), 127.5 (C), 127.2 (CH), 125.4
(CH), 124.8 (CH), 123.6 (2CH), 123.1 (CH), 122.0 (CH), 121.1
(CH), 46.7 (CH2), 46.3 (CH2); IR (neat): ν = 2970, 1769, 1735,
1698, 1470, 1409, 1067; HR-MS (ES-TOF): m/z: calcd for
C23H15NO3NaS: 408.0670, found 408.0667 [M + Na]
+.
1-(Dibenzo[b,d]thiophen-4-yl)-3-hydroxydecan-2-one (3g)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40 mg, 0.2 mmol), dec-1-yn-3-ol (64 µl, 0.4 mmol), toluene
(2 mL) and catalyst (11.2 mg, 5 mol%) for 4 hours at 0 °C and
stirring for a further 16 hours at rt. Purification of the reaction
mixture with column chromatography (9 : 1 hexane : EtOAc),
followed by recrystallization from hot MeOH aﬀorded 3g
(54 mg, 76%); Rf 0.25 (9 : 1 hexane : EtOAc); mp: 52–54 °C;
1H-NMR (300 MHz, CDCl3): δ = 8.21–8.14 (m, 1H), 8.11 (d,
J 7.9, 1H), 7.91–7.82 (m, 1H), 7.54–7.43 (m, 3H), 7.33 (d, J 7.2,
1H), 4.38 (dd, J 7.4 and 3.6, 1H), 4.07 (s, 2H), 3.33 (s, 1H),
2.02–1.88 (m, 1H), 1.75–1.62 (m, 1H), 1.59–1.16 (m, 10H), 0.88
(t, J 6.6, 3H); 13C-NMR (101 MHz, CDCl3): δ = 208.9 (C), 139.9
(C), 138.9 (C), 136.3 (C), 136.1 (C), 128.1 (CH), 127.9 (C), 127.1
(CH), 125.2 (CH), 124.8 (CH), 123.0 (CH), 122.0 (CH), 121.0
(CH), 76.4 (CH), 44.3 (CH2), 34.0 (CH2), 31.9 (CH2), 29.5 (CH2),
29.2 (CH2), 24.9 (CH2), 22.8 (CH2), 14.2(CH3); IR (neat): ν =
3446, 2924, 2854, 1714, 1585, 1443, 1402, 1047, 749; HR-MS
(ES-TOF): m/z: calcd for C22H26O2NaS: 377.1551, found
377.1565 [M + Na]+.
2-(Dibenzo[b,d]thiophen-4-yl)-1-phenylethanone (3h)
Prepared according to GP2 using dibenzothiophene-S-oxide 1
(60.0 mg, 0.3 mmol), phenylacetylene (65 µl, 0.6 mmol),
toluene (0.01 M, 30 mL) and catalyst (16.8 mg, 0.03 mmol,
5 mol%). Column chromatography (19 : 1 hexane : EtOAc), fol-
lowed by recrystallization from hot EtOAc aﬀorded 3h (53 mg,
58%) as a white solid; Rf 0.33 (19 : 1 hexane : EtOAc); mp:
127–129 °C; 1H-NMR (300 MHz, CDCl3): δ = 8.19–8.12 (m, 1H),
8.12–8.05 (m, 3H), 7.89–7.82 (m, 1H), 7.63–7.54 (m, 1H),
7.52–7.40 (m, 5H), 7.34 (d, J 6.9, 1H), 4.55 (s, 2H); 13C-NMR
(101 MHz, CDCl3): δ = 196.4 (C), 139.9 (C), 139.1 (C), 136.7 (C),
136.2 (2C), 133.5 (CH), 129.5 (C), 128.9 (2CH), 128.7 (2CH),
127.9 (CH), 127.0 (CH), 125.1 (CH), 124.7 (CH), 123.0 (CH),
122.0 (CH), 120.6 (CH), 44.7 (CH2); IR (neat): ν = 3056, 2924,
2856, 1685, 1580, 1440, 1206, 908; HR-MS (ES-TOF): m/z: calcd
for C20H14ONaS: 325.0663, found 325.0660 [M + Na]
+.
1-(2-Bromophenyl)-2-(dibenzo[b,d]thiophen-4-yl)ethanone (3i)
Prepared according to GP2 using dibenzothiophene-S-oxide 1
(40.0 mg, 0.2 mmol), 1-bromo-2-ethynylbenzene (50 µL,
0.4 mmol), toluene (20 mL, 0.01 mmol) and catalyst (11.2 mg,
0.02 mmol, 5 mol%). Column chromatography (19 : 1 hexane :
EtOAc) followed by recrystallization from hot EtOH aﬀorded 3i
(30.5 mg, 40%) as white needles; Rf 0.20 (19 : 1 hexane : EtOAc);
Paper Organic & Biomolecular Chemistry
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mp: 93–95 °C; 1H-NMR (300 MHz, CDCl3): δ = 8.18–8.12
(m, 1H), 8.09 (dd, J 7.7 and 1.1, 1H), 7.89–7.82 (m, 1H),
7.64–7.59 (m, 1H), 7.51–7.42 (m, 3H), 7.41–7.35 (m, 2H),
7.35–7.24 (m, 2H), 4.53 (s, 2H); 13C-NMR (101 MHz, CDCl3):
δ = 200.2 (C), 141.4 (C), 140.2 (C), 139.1 (C), 136.2 (C), 136.1
(2C), 133.7 (CH), 131.8 (CH), 128.8 (CH), 128.3 (CH), 127.6
(CH), 127.0 (CH), 125.1 (CH), 124.7 (CH), 123.0 (CH), 122.0
(CH), 120.8 (CH), 118.8(C), 48.7 (CH2); IR (neat): ν = 3054,
2940, 1703, 1591, 1441, 1332, 989, 742; HR-MS (ES-TOF): m/z:
calcd for C20H14OS
79Br: 380.9949, found 380.9948 [M + H]+.
2-(Dibenzo[b,d]thiophen-4-yl)-1-(4-methoxyphenyl)ethanone
(3j)
Prepared according to GP2 using dibenzothiophene-S-oxide 1
(40.0 mg, 0.2 mmol), 1-ethynyl-4-methoxybenzene (52 µl,
0.4 mmol), toluene (20 mL) and catalyst (11.2 mg, 0.02 mmol,
5 mol%). Column chromatography (19 : 1 hexane : EtOAc)
aﬀorded 3j (28 mg, 42%) as a white solid; Rf 0.18 (19 :
1 hexane : EtOAc); mp: 113–115 °C; 1H-NMR (300 MHz, CDCl3):
δ = 8.19–8.12 (m, 1H), 8.11–8.01 (m, 3H), 7.90–7.82 (m, 1H),
7.51–7.39 (m, 3H), 7.34 (d, J 7.2, 1H), 6.98–6.89 (m, 2H), 4.49
(s, 2H), 3.86 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ = 195.0 (C),
163.8 (C), 139.8 (C), 139.1 (C), 136.3 (C), 136.2 (C), 131.0 (2CH),
129.9 (C), 129.7 (C), 127.8 (CH), 126.9 (CH), 125.1 (CH), 124.7
(CH), 123.0 (CH), 122.0 (CH), 120.4 (CH), 114.0 (2CH), 55.6
(CH3), 44.4 (CH2); IR (neat): ν = 2910, 1717, 1593, 1508, 1400,
1167, 751; HR-MS (ES-TOF): m/z: calcd for C21H17O2NS:
333.0949, found 333.0950 [M + H]+.
2-(Dibenzo[b,d]thiophen-4-yl)-1-(thiophen-2-yl)ethanone (3k)
Prepared according to GP2 using dibenzothiophene-S-oxide 1
(40 mg, 0.2 mmol), 2-ethynylthiophene (44 µl, 0.4 mmol),
toluene (20 mL, 0.01 mmol) and catalyst (11.2 mg, 0.02 mmol,
5 mol%). Purification of the reaction mixture by column
chromatography (9 : 1 hexane : EtOAc) aﬀorded 3k (38 mg,
62%) as an orange oil; Rf 0.65 (9 : 1 hexane : EtOAc);
1H-NMR
(300 MHz, CDCl3): δ = 8.19–8.11 (m, 1H), 8.09 (dd, J 7.5 and
1.2, 1H), 7.90–7.82 (m, 2H), 7.65 (dd, J 4.9 and 0.7, 1H),
7.51–7.38 (m, 4H), 7.11 (dd, J 4.9 and 4.0, 1H), 4.46 (s, 2H);
13C-NMR (101 MHz, CDCl3): δ = 189.2 (C), 143.9 (C), 139.9 (C),
138.9 (C), 136.2 (C), 136.2 (C), 134.4 (CH), 132.9 (CH), 129.2
(C), 128.4 (CH), 127.8 (CH), 127.0 (CH), 125.1 (CH), 124.7 (CH),
123.0 (CH), 122.0 (CH), 120.7 (CH), 45.5 (CH2); IR (neat): ν =
3092, 3074, 1641, 1410, 1276, 1057, 750; HR-MS (EI-TOF): m/z:
calcd for C18H13OS2: 308.0330, found 308.0329 [M + H]
+.
1-(2,8-Dibromodibenzo[b,d]thiophen-4-yl)-3-methoxypropan-
2-one (6)
Sulfoxide 5 (71.6 mg, 0.2 mmol) was added to a 50 mL RBF
with methyl propargyl ether (34 µl, 0.4 mmol) and CHCl3
(30 mL). catalyst (11.2 mg, 0.01 mmol, 5 mol%) was added and
the mixture was stirred at rt for 17 hours. Purification by
column chromatography (CH2Cl2) aﬀorded 6 (58 mg, 70%) as
a white solid; Rf 0.07 (19 : 1 hexane : EtOAc); mp: 139–141 °C;
1H-NMR (300 MHz, CDCl3): δ = 8.18 (s, 1H), 8.12 (s, 1H), 7.68
(d, J 8.5, 1H), 7.56 (dd, J 8.5 and 1.3, 1H), 7.46 (s, 1H), 4.12 (s,
2H), 4.00 (s, 2H), 3.45 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ =
204.1 (C), 139.4 (C), 138.0 (C), 136.6 (C), 136.4 (C), 131.5 (CH),
130.6 (CH), 130.0 (C), 125.0 (CH), 124.3 (CH), 123.8 (CH), 119.1
(C), 119.0 (C), 77.6 (CH2), 59.6 (CH3), 44.8 (CH2); IR (neat): ν =
3067, 2901, 1723, 1567, 1410, 1319, 1072, 1042, 746; HR-MS
(ES-TOF): m/z: calcd for C16H12O2NaS
79Br81Br: 450.8802, found
450.8801 [M + Na]+.
1-(Allyloxy)-3-(dibenzo[b,d]thiophen-4-yl)propan-2-one (12a)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(100 mg, 0.5 mmol), 3-(prop-2-yn-1-yloxy)prop-1-ene 11a
(54 wt% in Et2O, 177 mg, 1.0 mmol), and catalyst (11.2 mg,
0.02 mmol, 2 mol%). The reaction mixture was stirred for
4 hours at 0 °C and left to warm to rt for a further 16 hours.
Column chromatography (CH2Cl2) aﬀorded 12a (119 mg, 80%)
as a yellow oil; Rf 0.34 (CH2Cl2);
1H-NMR (300 MHz, CDCl3):
δ = 8.19–8.14 (m, 1H), 8.10 (dd, J 7.9 and 1.0, 1H), 7.90–7.83
(m, 1H), 7.52–7.43 (m, 3H), 7.35 (d, J 7.2, 1H), 5.89 (ddt, J 17.2,
10.4 and 5.8, 1H), 5.27 (dd, J 17.2 and 1.5, 1H), 5.21 (dd, J 10.4
and 1.5, 1H), 4.18 (s, 2H), 4.06 (s, 2H), 4.06–4.02 (m, 2H);
13C-NMR (101 MHz, CDCl3): δ = 205.0 (C), 140.0 (C), 139.0 (C),
136.2 (C), 136.1 (C), 133.8 (CH), 128.3 (C), 128.1 (CH), 127.0
(CH), 125.2 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 120.8
(CH), 118.3 (CH2), 74.8 (CH2), 72.6 (CH2), 45.6 (CH2); IR (neat):
ν = 2901, 1726, 1554, 1443, 1402, 1096, 912; HR-MS (ES-TOF):
m/z: calcd for C18H16O2SNa: 319.0769, found 319.0775
[M + Na]+.
N-Allyl-N-(3-(dibenzo[b,d]thiophen-4-yl)-2-oxopropyl)-
4-methylbenzenesulfonamide (12c)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40 mg, 0.2 mmol), N-allyl-4-methyl-N-(prop-2-yn-1-yl)benzene-
sulfonamide 11c (96 mg, 0.4 mmol), and catalyst (11.2 mg,
0.02 mmol, 5 mol%). The reaction mixture was stirred for
2.5 hours at 0 °C. Column chromatography (9 : 1 hexane :
EtOAc) followed by recrystallization from hot MeOH aﬀorded
12c (66 mg, 74%) as a white solid; Rf 0.31 (9 : 1 hexane : EtOAc);
mp: 104–106 °C; 1H NMR (300 MHz, CDCl3): δ = 8.21–8.14 (m,
1H), 8.11 (dd, J 8.1, 0.9, 1H), 7.91–7.82 (m, 1H), 7.65 (d, J 8.3,
2H), 7.53–7.43 (m, 3H), 7.32 (d, J 7.2, 1H), 7.21 (d, J 8.1, 2H),
5.58 (ddt, J 16.9, 10.1 and 6.8, 1H), 5.03 (dd, J 10.1, 1.1, 1H),
4.96 (dd, J 16.9, 1.1, 1H) 4.10 (s, 2H), 4.01 (s, 2H), 3.78 (d, J 6.7,
2H), 2.36 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ = 201.9 (C),
143.7 (C), 140.0 (C), 139.0 (C), 136.3 (C), 136.2 (C), 136.0 (C),
132.1 (CH), 129.8 (2CH), 128.2 (CH), 128.0 (C), 127.6 (2CH),
127.1 (CH), 125.3 (CH), 124.8 (CH), 123.0 (CH), 122.0 (CH),
120.9 (CH), 120.5 (CH2) 54.4 (CH2), 51.4 (CH2), 46.4 (CH2), 21.6
(CH3); IR (neat): ν = 1731, 1443, 1397, 1153, 1045, 924, 752;
HR-MS (ES-TOF): m/z: calcd for C25H24NO3S2: 450.1198, found
450.1180 [M + H]+.
1-(Allyloxy)-3-(5-oxidodibenzo[b,d]thiophen-4-yl)propan-2-one
(14)
mCPBA (72.3 mg, 0.42 mmol, 1.1 equiv.) was added in 5 por-
tions over 10 minutes to a solution of 12a (113 mg, 0.38 mmol)
in CH2Cl2 (10 mL) at 0 °C. The reaction was allowed to warm
Organic & Biomolecular Chemistry Paper
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to rt over 2 hours, washed with NaHCO3 (4 × 10 mL), extracted
with CH2Cl2 (4 × 10 mL), dried over Na2SO4, filtered and con-
centrated under reduced pressure. Purification by column
chromatography (4 : 1 hexane : EtOAc to EtOAc) aﬀorded firstly
12a (25 mg, 22%) and then 14 (74 mg, 62%) as a white solid;
Rf 0.37 (3 : 7 hexane : EtOAc); mp: 98–100 °C;
1H-NMR
(300 MHz, CDCl3): δ = 7.96 (d, J 7.5, 1H), 7.80 (d, J 7.6, 1H),
7.74 (d, J 7.5, 1H), 7.64–7.53 (m, 2H), 7.50 (td, J 7.5 and 0.9,
1H), 7.29 (d, J 7.6, 1H), 5.94 (ddt, J 17.2, 10.5 and 5.7, 1H), 5.32
(dd, J 17.2 and 1.5, 1H), 5.24 (dd, J 10.5 and 1.2, 1H), 4.38–4.17
(m, 4H), 4.11 (d, J 5.8, 2H); 13C-NMR (101 MHz, CDCl3): δ =
204.6 (C), 144.7 (C), 144.0 (C), 137.7 (C), 137.3 (C), 135.0 (C),
133.9 (CH), 132.7 (CH), 132.7 (CH), 131.7 (CH), 129.7 (CH),
127.5 (CH), 122.2 (CH), 121.0 (CH), 118.3 (CH2), 75.1 (CH2),
72.7 (CH2), 42.5 (CH2); IR (neat): ν = 3050, 2857, 1725, 1551,
1485, 1424, 1321, 1161, 1145, 1070, 1045, 1012, 762; HR-MS
(ES-TOF): m/z: calcd for C18H17O3S: 313.0898, found 313.0906
[M + H]+.
3,3′-(Dibenzo[b,d]thiophene-4,6-diyl)bis(1-(allyloxy)propan-
2-one) (16a)
Sulfoxide 14 (68 mg, 0.22 mmol) and enyne 11a (54 wt% in
Et2O, 78.3 mg, 0.44 mmol) were dissolved in toluene (8.8 mL,
0.025 M). After stirring for 20 minutes the reaction mixture
was transferred to an ice bath at 0 °C. (2,4-Di-tert-butylC6H3O)3-
PAu(NCCH3)SbF6 (12.3 mg, 0.011 mmol, 5 mol%) was added
with a further portion (6.1 mg, 5.5 μmol, 2.5 mol%) added
after 3 hours with the reaction mixture then stirred for a
further 1 hour at 0 °C. The reaction mixture was filtered
through a plug of silica and washed with CH2Cl2 (10 mL). The
reaction mixture was concentrated under reduced pressure
and purified by column chromatography (4 : 1 hexane : EtOAc)
providing 16a (65 mg, 73%) as a white solid; Rf 0.58 (1 :
1 hexane : EtOAc); mp: 77–80 °C; 1H-NMR (300 MHz, CDCl3):
δ = 8.08 (d, J 7.7, 2H), 7.47 (app t, J 7.6, 2H), 7.34 (d, J 7.2, 2H),
5.90 (ddt, J 17.2, 10.4 and 5.7, 2H), 5.27 (app d, J 17.2, 2H),
5.21 (app d, J 10.4, 2H) 4.17 (s, 4H), 4.11–4.01 (m, 8H);
13C-NMR (101 MHz, CDCl3): δ = 204.8 (2C), 139.5 (2C), 136.6
(2C), 133.8 (2CH), 128.3 (2CH), 128.3 (2C), 125.4 (2CH), 121.0
(2CH), 118.3 (2CH2), 74.8 (2CH2), 72.6 (2CH2), 45.6 (2CH2); IR
(neat): ν = 2855, 1722, 1574, 1426, 1390, 1331, 1164, 1060,
1045; HR-MS (ES-TOF): m/z: calcd for C24H24O4NaS: 431.1293,
found 431.1288 [M + Na]+.
1-(Allyloxy)-3-(6-(3-(but-3-en-1-yloxy)-2-oxopropyl)dibenzo[b,d]-
thiophen-4-yl)propan-2-one (16b)
Sulfoxide 14 (60 mg, 0.192 mmol) and enyne 15 (77 wt% in
Et2O, 50 mg, 0.348 mmol) were dissolved in toluene (0.025 M,
10 mL). After stirring for 20 minutes at rt the reaction was
transferred to an ice bath at 0 °C and (2,4-di-tert-butylC6H3O)3-
PAu(NCCH3)SbF6 (7.5 mol%) was added. The reaction was
stirred for 4 hours filtered through a pad of silica washing
with CH2Cl2, concentrated and purified by column chromato-
graphy (4 : 1 hexane : EtOAc) to aﬀord 16b (68 mg, 83%) as an
oﬀ white solid; Rf 0.81 (1 : 1 hexane : EtOAc); mp: 57–59 °C;
1H-NMR (300 MHz, CDCl3): δ = 8.02 (dd, J 7.9 and 0.8, 2H),
7.40 (app t, J 7.6, 2H), 7.28 (d, J 7.3, 2H), 5.91–5.68 (m, 2H),
5.21 (dd, J 17.2 and 1.6, 1H), 5.15 (dd, J 10.2 and 1.6, 1H), 5.04
(dd, J 17.2 and 1.6, 1H), 4.97 (dd, J 10.2 and 1.6, 1H), 4.10
(s, 4H), 4.02–3.96 (m, 6H), 3.48 (t, J 6.7, 2H), 2.37–2.27 (m, 2H);
13C-NMR (101 MHz, CDCl3): δ = 205.1 (C), 204.9 (C), 139.6
(2C), 136.7 (2C), 134.9 (CH), 133.8 (CH), 128.3 (2CH), 128.2
(2C), 125.4 (2CH), 121.0 (2CH), 118.3 (CH2), 117.0 (CH2), 75.9
(CH2), 74.8 (CH2), 72.6 (CH2), 71.3 (CH2), 45.6 (2CH2), 34.2
(CH2); IR (neat): ν = 2860, 1721, 1644, 1575, 1476, 143, 1061,
913, 776; HR-MS (ES-TOF): m/z: calcd for C25H26O4NaS:
445.1450, found 445.1429 [M + Na]+.
Macrocycle 17a
[1,3-Bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-
(phenylmethylene)(tricyclohexylphosphine)ruthenium (10.4 mg,
0.012 mmol) was added to a solution of 16a (100 mg,
0.245 mmol) in CH2Cl2 (25 mL). The reaction mixture was
heated to reflux for 1 hour, allowed to cool, concentrated and
purified by column chromatography (3 : 7 hexane : EtOAc) to
aﬀord 17a (80 mg, 86%) as a white solid; Rf 0.58 (1 : 1 hexane :
EtOAc); mp: 165–167 °C; 1H-NMR (300 MHz, CDCl3): δ = 8.08 (d,
J 7.2, 2H), 7.48 (app t, J 7.6, 2H), 7.39 (d, J 7.0, 2H), 5.74–5.60
(m, 2H), 4.19 (s, 4H), 4.02 (s, 4H), 3.96 (dd, J 3.0 and 1.3, 4H);
13C-NMR (101 MHz, CDCl3): δ = 205.0 (2C), 139.2 (2C), 136.7
(2C), 130.2 (2CH), 128.1 (2CH), 128.1 (2C), 125.7 (2CH), 121.1
(2CH), 74.3 (2CH2), 71.1 (2CH2), 45.6 (2CH2); IR (neat): ν = 2855,
1722, 1574, 1426, 1390, 1331, 1144, 1060, 1045, 919, 776, 731;
HR-MS (ES-TOF): m/z: calcd for C22H20O4NaS: 403.0980, found
403.0996 [M + Na]+.
Macrocycle 17b
[1,3-Bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-
(phenylmethylene)(tricyclohexylphosphine)ruthenium (5.0 mg,
0.006 mmol) was added to a solution of 16b (50 mg,
0.118 mmol) in CH2Cl2 (25 mL). The reaction mixture was
heated to reflux for 2 hours, concentrated and purified by
column chromatography (3 : 7 hexane : EtOAc) to aﬀord 17b
(35 mg, 70%) as a white solid; Rf 0.48 (1 : 1 hexane : EtOAc);
mp: 138–139 °C; 1H-NMR (300 MHz, CDCl3): δ = 8.07 (d, J 7.8,
2H), 7.48 (td, J 7.6 and 3.1, 2H), 7.37 (d, J 5.1, 2H), 6.11–5.95
(m, 1H), 5.69 (dt, J 15.0 and 5.6, 1H), 4.18 (s, 4H), 4.15–4.05
(m, 6H), 3.64 (t, J 5.8, 2H), 2.42 (dd, J 11.6 and 5.6, 2H);
13C-NMR (101 MHz, CDCl3): δ = 206.6 (C), 205.8 (C), 139.2 (C),
139.1 (C), 136.7 (C), 136.6 (C), 132.0 (CH), 128.7 (CH), 128.7
(CH), 128.4 (C), 128.4 (C) 127.4 (CH), 125.4 (2CH), 121.0 (CH),
120.9 (CH), 76.3 (CH2), 74.4 (CH2), 71.7 (CH2), 71.2 (CH2), 44.7
(CH2), 44.2 (CH2), 32.8 (CH2); IR (neat): ν = 2861, 1720, 1644,
1575, 1426, 1143, 1062, 914, 775; HR-MS (ES-TOF): m/z: calcd
for C23H22O4NaS: 417.1137, found 417.1136 [M + Na]
+.
3-(Dibenzo[b,d]thiophen-4-yl)-2-phenyl-1H-indole (18)
To 3h (55 mg, 0.183 mmol, 1.0 eq.) was added AcOH (0.80 ml),
TFA (0.28 ml) and phenylhydrazine (45 µL, 0.46 mmol, 2.5 eq.)
in a sealed (Ace) tube. The reaction was stirred at 100 °C for
28 hours at which point reaction completion was observed by
TLC. The mixture was added to ice/water (10 mL), the mixture
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was extracted with CH2Cl2 (10 mL × 3) and the organic por-
tions were washed with HCl (1 M, 5 mL), water (5 mL), dried
over Na2SO4, concentrated and purified by column chromato-
graphy (9 : 1 hexane : EtOAc) to aﬀord 18 (45.6 mg, 66%) as a
viscous orange oil; Rf 0.31 (9 : 1 hexane : EtOAc);
1H-NMR
(300 MHz, CDCl3): δ = 8.46 (s, 1H), 8.21 (ddd, J 7.6, 5.6 and 1.4,
2H), 7.77–7.70 (m, 1H), 7.59–7.48 (m, 3H), 7.48–7.41 (m, 3H),
7.40–7.34 (m, 2H), 7.33–7.20 (m, 4H), 7.13 (td, J 7.6 and 0.9,
1H); 13C-NMR (101 MHz, CDCl3): δ = 141.4 (C), 140.1 (C), 136.1
(C), 136.0 (2C), 134.8 (C), 132.5 (C), 130.5 (C), 129.3 (CH), 128.9
(2CH), 128.8 (C), 127.9 (CH), 127.3 (2CH), 126.7 (CH), 125.0
(CH), 124.3 (CH), 123.0 (CH), 122.9 (CH), 121.8 (CH), 120.4
(CH), 120.4 (CH), 120.3 (CH), 113.5 (C), 111.1 (CH); IR (neat):
ν = 3408, 3057, 1578, 1487, 1442, 1384, 1253, 905, 742, 693;
HR-MS (ES-TOF): m/z: calcd for C26H18NS: 376.1160, found
376.1170 [M + H]+.
Diethyl 4-(dibenzo[b,d]thiophen-4-yl)-3-methyl-5-oxocyclohex-
3-ene-1,1-dicarboxylate (20) and diethyl 2-(3-(dibenzo[b,d]-
thiophen-4-yl)-2-oxopropyl)-2-(2-oxopropyl)malonate (21)
Prepared according to GP1 using dibenzothiophene-S-oxide 1
(40 mg, 0.2 mmol), diyne 19 (48.6 mg, 0.4 mmol), toluene
(2 mL) and catalyst (11.2 mg, 5 mol%). The reaction was
stirred for 2 hours at 0 °C before allowing to warm to rt for
17 hours. Column chromatography (3 : 7 hexane : CH2Cl2 to
CH2Cl2) aﬀorded 20 (49 mg, 57%) as a colourless oil and 21
(15 mg, 17%) as a colourless oil.
20 Rf 0.48 (3 : 7 hexane : EtOAc);
1H NMR (300 MHz, CDCl3):
δ = 8.13 (ddd, J 12.9, 5.7 and 2.4, 2H), 7.83–7.75 (m, 1H),
7.55–7.37 (m, 3H), 7.11 (dd, J 7.2 and 1.0, 1H), 4.44–4.21 (m,
4H), 3.32–2.94 (m, 4H), 1.85 (s, 3H), 1.32 (t, J 7.1, 3H), 1.31 (t,
J 7.1, 3H),; 13C NMR (101 MHz, CDCl3): δ = 192.4 (C), 169.9 (C),
169.8 (C) 156.3 (C), 156.3 (C), 140.1 (C), 139.4 (C), 136.1 (C),
136.1 (C) 135.8 (C), 128.2 (CH), 126.8 (CH), 124.7 (CH), 124.5
(CH), 122.8 (CH), 121.8 (CH), 121.0 (CH), 62.6 (CH2), 62.4
(CH2), 55.0 (C), 42.6 (CH2), 37.5 (CH2), 22.7 (CH3), 14.2 (2CH3);
IR (neat): ν = 2982, 1729, 1673, 1302, 1250, 1167, 752; HR-MS
(ES-TOF): m/z: calcd for C25H24O5NaS: 459.1242, found
459.1229 [M + Na]+.
21 Rf 0.42 (7 : 3 hexane : EtOAc);
1H NMR (300 MHz, CDCl3):
δ = 8.18–8.12 (m, 1H), 8.09 (dd, J 7.9 and 0.9, 1H), 7.87–7.81
(m, 1H), 7.50–7.42 (m, 3H), 7.31 (d, J 7.0, 1H), 4.13 (q, J 7.1,
2H), 4.12 (q, J 7.1, 2H), 3.97 (s, 2H), 3.50 (s, 2H), 3.31 (s, 2H),
1.99 (s, 3H), 1.17 (t, J 7.0, 6H); 13C NMR (101 MHz, CDCl3): δ =
206.0 (C), 204.6 (C), 169.5 (2C), 139.9 (C), 139.1 (C), 136.3 (C),
136.0 (C), 128.4 (CH), 128.2 (C), 127.1 (CH), 125.3 (CH), 124.8
(C), 122.9 (C), 122.0 (CH), 120.8 (CH), 62.1 (2CH2), 53.2 (C),
49.4 (CH2), 45.8 (CH2), 44.9 (CH2), 30.2 (CH3), 14.0 (2CH3); IR
(neat): ν = 2982, 2930, 1719, 1444, 1403, 1364, 1201, 1096, 754;
HR-MS (ES-TOF): m/z: calcd for C25H26O6SNa: 477.1348, found
477.1339 [M + Na]+.
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